Search
wechseln zu deutsch deutsch english
Home General For Authors Subscription Full Text Articles

 

Sci. Pharm. 2013; 81: 1–13

Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective

Dipika BANSAL *, Swathi MALLA, Kapil GUDALA, Pramil TIWARI

Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S Nagar, Punjab-160062, India.

* Corresponding author. E-mail: drdeep97@mail.com (D. Bansal)

Abstract

Growth of international free trade and inadequate drug regulation have led to the expansion of trade in counterfeit drugs worldwide. Technological protection is seen to be the best way to avoid this problem. Different technologies came into existence like overt, covert, and track and trace technologies. This review emphasises ideal technological characteristics, existing anti-counterfeit technologies, and their adoption in different countries. Developed countries like the USA have implemented RFID while the European trend is towards 2D barcodes. The Indian government is getting sensitised about the extent of the problem and has formulated rules mandating barcodes. Even the pharmaceutical companies have been employing these technologies in order to detain illegitimate drugs in their supply chain.

Keywords

Authentication Anti-counterfeit technology RFID Pedigree Serialization

Received February 7th, 2012 | Accepted October 9th, 2012 | Published Online October 9th, 2012

http://dx.doi.org/10.3797/scipharm.1202-03